MPM BioImpact LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
MPM BioImpact LLC
CIK #0001687078
Sector Form 13F Holdings Value ($M)
Cullinan Oncology Inc 57.6
Synta Pharmaceuticals Corp 30.4
Zai Lab Ltd 26.1
Guardant Health Inc 23.0
Silverback Therapeutics Inc 22.7
Edgewise Therapeutics Inc 22.6
Avidity Biosciences Inc 21.6
PTC Therapeutics Inc 21.4
Trevi Therapeutics Inc 18.6
Oric Pharmaceuticals Inc 17.6
View All
Holdings by Sector ($M)
120096072048024002020202220242026
EDGAR Form CIK 2011 - 2025
13F-HR [0001687078]
3 [0001687078]
4 [0001687078]
SC 13D [0001687078]
SC 13G [0001687078]
Form 13D/13G Filer Form 13D/13G Subject Filed
MPM Bioimpact LLC Compass Therapeutics Inc [2025-02-14]
MPM Bioimpact LLC Context Therapeutics Inc [2025-01-08]
Bioimpact Capital LLC Reunion Neuroscience Inc [2023-06-12]
Form 3/4/5 Subject 2011 - 2025
iTeos Therapeutics, Inc.
MPM BioImpact LLC
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
Gadicke Ansbert
MPM Oncology Innovations Fund GP LLC
MPM Asset Management LLC
MPM Oncology Innovations Fund LP
Werewolf Therapeutics, Inc.
TCR2 Therapeutics Inc
Cullinan Therapeutics, Inc.
MPM Oncology Impact Management GP LLC
Harpoon Therapeutics, Inc.
Oncorus, Inc.
F-star Therapeutics, Inc.
Viracta Therapeutics, Inc.
Terms | Privacy | Guide
tony@aum13f.com